Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Open-label, Randomized, Crossover, Comparative Bioavailability Study of Levodopa Administered Via Levodopa Cyclops® (Test Product) Relative to INBRIJA® (Reference Product) in Healthy Adult Subjects

NCT06037590 is registered in ClinicalTrials.gov with PureIMS B.V. as lead sponsor.

NCT NCT06037590
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06037590 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Open-label, Randomized, Crossover, Comparative Bioavailability Study of Levodopa Administered Via Levodopa Cyclops® (Test Product) Relative to INBRIJA® (Reference Product) in Healthy Adult Subjects
Lead sponsor
PureIMS B.V.
Phase
Phase 1
Overall status
Completed
Start date
September 25, 2023
Completion date
October 27, 2023
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson, parkinson disease, parkinson's disease and parkinsonism